Understanding how these medications affect digestive function is essential for both clinicians and patients, particularly when evaluating symptoms such as nausea, bloating, and potential reflux-related complaints
Recent FDA Approvals and the Future of GLP-1 Agonists The pronounced success of GLP-1-based therapies has led to numerous FDA approvals for managing type 2 diabetes and obesity (Kommu S et al., 2025
Safety Considerations Before Choosing a Lower-Cost Option If youre exploring affordable tirzepatide options, a few safeguards matter
This result concurs with the report that GLP-1R-immunoreactivity occurs in the neurons of the rat GCL [10,11,12]
Konopleva, M, Zhao S, Xie Z, Andreeff M
This decision matters because bariatric surgery patients face unique risks: malabsorption, dumping syndrome, dehydration, and nutritional deficiencies